Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Ferlay, Hai-rim Shin, F. Bray, D. Forman, C. Mathers, D. Parkin (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 127
T. Beyer, D. Townsend, T. Brun, Paul Kinahan, M. Charron, R. Roddy, J. Jerin, J. Young, L. Byars, R. Nutt (2000)
A combined PET/CT scanner for clinical oncology.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 41 8
S. Fenchel, D. Grab, K. Nuessle, J. Kotzerke, A. Rieber, R. Kreienberg, H. Brambs, S. Reske (2002)
Asymptomatic adnexal masses: correlation of FDG PET and histopathologic findings.Radiology, 223 3
Shanshan Liao, X. Lan, Guoxiang Cao, Huiyu Yuan, Yongxue Zhang (2013)
Prognostic Predictive Value of Total Lesion Glycolysis From 18F-FDG PET/CT in Post-Surgical Patients With Epithelial Ovarian CancerClinical Nuclear Medicine, 38
Wei Huang, Tao Zhou, Li Ma, Hong-fu Sun, H. Gong, Juan Wang, Jinming Yu, Baosheng Li (2011)
Standard uptake value and metabolic tumor volume of 18F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 38
Jae Lee, K. Min, K. So, Sungeun Kim, J. Hong (2014)
The effectiveness of dual-phase 18F-FDG PET/CT in the detection of epithelial ovarian carcinoma: a pilot studyJournal of Ovarian Research, 7
H. Lerman, U. Metser, D. Grisaru, A. Fishman, Gennady Lievshitz, E. Even-Sapir (2004)
Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 45 2
Danny Costantini, R. Vali, J. Chan, Susan McQuattie, M. Charron (2013)
Dual-time-point FDG PET/CT for the evaluation of pediatric tumors.AJR. American journal of roentgenology, 200 2
Priyanka Prakash, C. Cronin, M. Blake (2010)
Role of PET/CT in ovarian cancer.AJR. American journal of roentgenology, 194 6
L. Kostakoglu, H. Agress, S. Goldsmith (2003)
Clinical role of FDG PET in evaluation of cancer patients.Radiographics : a review publication of the Radiological Society of North America, Inc, 23 2
A. Rieber, K. Nüssle, Iris Stöhr, D. Grab, S. Fenchel, R. Kreienberg, S. Reske, H. Brambs (2001)
Preoperative diagnosis of ovarian tumors with MR imaging: comparison with transvaginal sonography, positron emission tomography, and histologic findings.AJR. American journal of roentgenology, 177 1
R. Bast, B. Hennessy, G. Mills (2009)
The biology of ovarian cancer: new opportunities for translationNature Reviews Cancer, 9
R. Forstner, H. Hricak, K. Occhipinti, C. Powell, S. Frankel, J. Stern (1995)
Ovarian cancer: staging with CT and MR imaging.Radiology, 197 3
I. Ciernik, E. Dizendorf, B. Baumert, B. Reiner, C. Burger, J.Bernard Davis, U. Lütolf, H. Steinert, G. Schulthess (2003)
Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study.International journal of radiation oncology, biology, physics, 57 3
J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, D. Parkin, D. Forman, F. Bray (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 136
H. Zhang, K. Wroblewski, S. Liao, R. Kampalath, B. Penney, Yi Zhang, Y. Pu (2013)
Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.Academic radiology, 20 1
M. Caprio, A. Cangiano, M. Imbriaco, F. Soscia, G. Martino, Alessandra Farina, G. Avitabile, L. Pace, P. Forestieri, M. Salvatore (2010)
Dual-time-point [18F]-FDG PET/CT in the diagnostic evaluation of suspicious breast lesionsLa radiologia medica, 115
H. Zhuang, M. Pourdehnad, E. Lambright, A. Yamamoto, M. Lanuti, Peiyong Li, P. Mozley, M. Rossman, S. Albelda, A. Alavi (2001)
Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 42 9
C. Costelloe, H. Macapinlac, J. Madewell, N. Fitzgerald, O. Mawlawi, E. Rohren, A. Raymond, Valerae Lewis, P. Anderson, R. Bassett, R. Harrell, E. Marom (2009)
18F-FDG PET/CT as an Indicator of Progression-Free and Overall Survival in OsteosarcomaJournal of Nuclear Medicine, 50
Jang Yoo, J. Choi, Kyu Lee, J. Heo, Soo Park, S. Moon, Y. Choe, Kyung-Han Lee, Byung‐Tae Kim (2012)
Prognostic Significance of Volume-based Metabolic Parameters by 18F-FDG PET/CT in Gallbladder CarcinomaNuclear Medicine and Molecular Imaging, 46
H. Chung, Hyun Kwon, K. Kang, J. Kim, N. Park, Y. Song, Soon-Beom Kang (2012)
Preoperative [18F]FDG PET/CT predicts recurrence in patients with epithelial ovarian cancerJournal of Gynecologic Oncology, 23
Ho Lee, S. Hyun, K. Lee, Byung-Tae Kim, Jhingook Kim, Y. Shim, M. Ahn, T. Kim, C. Yi, M. Chung (2010)
Volume-Based Parameter of 18F-FDG PET/CT in Malignant Pleural Mesothelioma: Prediction of Therapeutic Response and Prognostic ImplicationsAnnals of Surgical Oncology, 17
S. Rosenbaum, T. Lind, G. Antoch, A. Bockisch (2006)
False-Positive FDG PET Uptake−the Role of PET/CTEuropean Radiology, 16
MG Caprio, A Cangiano, M Imbriaco, F Soscia, G Martino, A Farina (2010)
Dual-time-point [18F]-FDG PET/CT in the diagnostic evaluation of suspicious breast lesionsRadiol Med, 115
G. Cheng, D. Torigian, H. Zhuang, A. Alavi (2013)
When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET?European Journal of Nuclear Medicine and Molecular Imaging, 40
Michael Adams, T. Turkington, Joshua Wilson, T. Wong (2010)
A systematic review of the factors affecting accuracy of SUV measurements.AJR. American journal of roentgenology, 195 2
M. Boente, J. Hurteau, G. Rodriguez, R. Bast, A. Berchuck (1993)
The biology of ovarian cancerCurrent Opinion in Oncology, 5
S. Risum, C. Høgdall, A. Loft, A. Berthelsen, E. Høgdall, L. Nedergaard, L. Lundvall, S. Engelholm (2007)
The diagnostic value of PET/CT for primary ovarian cancer--a prospective study.Gynecologic oncology, 105 1
T. Miller, E. Pinkus, F. Dehdashti, P. Grigsby (2003)
Improved prognostic value of 18F-FDG PET using a simple visual analysis of tumor characteristics in patients with cervical cancer.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 44 2
S Liao, BC Penney, K Wroblewski, H Zhang, CA Simon, R Kampalath (2012)
Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancerEur J Nucl Med Mol Imaging, 39
M. Hatt, D. Visvikis, N. Albarghach, F. Tixier, O. Pradier, C. Rest (2011)
Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodologyEuropean Journal of Nuclear Medicine and Molecular Imaging, 38
R. Hustinx, Robin Smith, F. Bénard, D. Rosenthal, M. Machtay, Leonard Farber, A. Alavi (1999)
Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neckEuropean Journal of Nuclear Medicine, 26
C. Tempany, K. Zou, S. Silverman, Douglas Brown, A. Kurtz, B. McNeil (2000)
Staging of advanced ovarian cancer: comparison of imaging modalities--report from the Radiological Diagnostic Oncology Group.Radiology, 215 3
Sinae Lee, T. Park, Soyeon Park, K. Pahk, Seunghong Rhee, Jaehyuk Cho, Eugene Jeong, Sungeun Kim, J. Choe (2013)
The Clinical Role of Dual-Time-Point 18F-FDG PET/CT in Differential Diagnosis of the Thyroid IncidentalomaNuclear Medicine and Molecular Imaging, 48
H. Chung, J. Kim, K. Han, J. Eo, K. Kang, N. Park, Y. Song, June-Key Chung, Soon-Beom Kang (2011)
Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer.Gynecologic oncology, 120 2
J. Ferlay, I. Soerjomataram, M. Ervik, R. Dikshit, S. Eser, C. Mathers (2013)
GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer
Nucl Med Mol Imaging (2015) 49:42–51 DOI 10.1007/s13139-014-0303-3 ORIGINAL ARTICLE Value of F-FDG PET/CT in the Detection of Ovarian Malignancy Taegyu Park & Sinae Lee & Soyeon Park & Eunsub Lee & Kisoo Pahk & Seunghong Rhee & Jaehyuk Cho & Chulhan Kim & Jae Seon Eo & Jae Gol Choe & Sungeun Kim Received: 26 August 2014 /Revised: 14 October 2014 /Accepted: 16 October 2014 /Published online: 28 October 2014 Korean Society of Nuclear Medicine 2014 Abstract visual characteristics of each peritoneal lesion, including met- Purpose Ovarian cancer is a leading cause of gynecologic abolic extent, intensity, shape, heterogeneity, and total visual malignancy. As symptoms of ovarian cancer are nonspecific, score. Associations between visual grades and malignancy only 20 % of ovarian cancers are diagnosed while they are still were analyzed using linear by linear association methods. limited to the ovaries. Thus, early and accurate detection of Moreover, a receiver operating characteristic (ROC) curve disease is important for an improved prognosis. For the accu- was analyzed to compare the effectiveness of significant rate and effective diagnosis of ovarian malignancy on F- parameters. fluorodeoxyglucose ( F-FDG) positron emission Result In a comparison between the malignant and benign tomography/computed tomography
Nuclear Medicine and Molecular Imaging – Springer Journals
Published: Oct 28, 2014
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.